coronavir coronavir coronavir is an anti-viral drug approved in russia for the treatment of covid-19. little is known of this drug, except for the information released by its developer r-pharm. novel coronavirus sars-cov-2 by the description provided to the press, coronavir seems to be an inhibitor of sars-cov-2 rna polymerase, similar to other antiviral nucleotide analogues such as remdesivir. the drug appears to be based on favipiravir, a drug developed in japan. coronavir was approved for use in russia in hospitals in july 2020, and in september 2020 it received approval for prescription sales for outpatient use.